Hello everyone,

How many times have I wished to live multiple lives and see what would have happened if I had chosen this or that path? What would have happened if I had chosen to do a PhD in nutrigenomics, plants or cancer rather than in the degradation of proteins? While through the PhD, I got to know a lot about a little, here at Capital Cell, I get to know a little about a lot and I am fulfilling my curiosity thanks to all the amazing proposals that we receive.

Today I had the chance to witness (by means of this pitch deck) the evolution of cancer therapeutics. The English company Antikor is designing drugs -Fragment Drug Conjugates- to kill specific cells, only the cancerous ones.

Antikor crowdfunding

I kindly ask you to review this proposal and share your opinion with me through the questionnaire.

With best wishes,

Pilar Puig Sàrries





Leave a reply

©2024 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

Aviso de cookies

Log in with your credentials


Forgot your details?

Create Account

Skip to toolbar